blog

Ramping Up Patient & Site Engagement during COVID-19

By Elizabeth Gargill on Tue, Apr 14, 2020 | 6 min read

 

Guidance to Help Respond to Immediate Challenges 

As the COVID-19 outbreak challenges clinical trial sponsors, we’ve identified efforts to support patient and site engagement -  helping to minimize clinical trial disruption and keep timelines intact. Some efforts respond to FDA guidance on conducting clinical trials during the COVID-19 pandemic while others respond to challenges introduced by travel restrictions, infection risks, enhanced site burden, and protocol deviations.

Topics: Patient Engagement, Site Engagement, RSG Arrive, COVID-19

Minimizing Clinical Trial Disruption from COVID-19

By Elizabeth Gargill on Thu, Apr 2, 2020 | 2 min read

 

We are closely monitoring the COVID-19 outbreak and its impact on clinical trial patient recruitment, engagement, and compliance. As the health and wellbeing of patients remains our priority, we’ve outlined key solutions clinical trial sponsors can quickly deploy to enhance compliance and ensure patients are able to continue with their clinical trial participation.

Topics: Patient Engagement, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

 
Subscribe To Our Blog